Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury

Background Shrunken pore syndrome (SPS) as a novel phenotype of renal dysfunction is characterized by a difference in renal filtration between cystatin C and creatinine. The manifestation of SPS was defined as a cystatin C-based estimated glomerular filtration rate (eGFR)

Saved in:
Bibliographic Details
Published in:Journal of the American Heart Association 2023-01, Vol.12 (1), p.e027980-e027980
Main Authors: Zhang, Li-Wei, Luo, Man-Qing, Xie, Xian-Wei, You, Zhe-Bin, Zeng, Ji-Lang, Lin, Mao-Qing, Chen, Li-Chuan, Lin, Kai-Yang, Guo, Yan-Song
Format: Article
Language:English
Subjects:
Acute Kidney Injury - chemically induced
Acute Kidney Injury - diagnosis
contrast‐associated acute kidney injury
Creatinine
Cystatin C
Glomerular Filtration Rate
Humans
Original Research
outcome
percutaneous coronary intervention
Phenotype
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - epidemiology
Retrospective Studies
Risk Factors
shrunken pore syndrome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Shrunken pore syndrome (SPS) as a novel phenotype of renal dysfunction is characterized by a difference in renal filtration between cystatin C and creatinine. The manifestation of SPS was defined as a cystatin C-based estimated glomerular filtration rate (eGFR)
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.122.027980